Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037804 · ClinicalTrials.gov registry record · Phase 1
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00037804 is a Phase 1 study that has completed, run by Pfizer.
The verdict
NCT00037804, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Drugs used in chemotherapy us different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with refractory solid tumors and liver dysfunction.
Interventions
- DRUG Irinotecan
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00037804
The ClinicalTrials.gov registry entry for NCT00037804 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Irinotecan is the first listed.
NCT00037804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00037804 about?
NCT00037804 is a clinical study titled "Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction". Drugs used in chemotherapy us different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with refractory solid tumors and liver dysfunction.
What is the current status of trial NCT00037804?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00037804?
The interventions under investigation include: Irinotecan (DRUG).
Who is sponsoring clinical trial NCT00037804?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.